HEADER HYDROLASE/HYDROLASE INHIBITOR 21-AUG-20 7JVN TITLE NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH TITLE 2 ALLOSTERIC INHIBITOR COMPOUND 24 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE 11; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN-TYROSINE PHOSPHATASE 1D,PTP-1D,PROTEIN-TYROSINE COMPND 5 PHOSPHATASE 2C,PTP-2C,SH-PTP2,SHP2,SH-PTP3; COMPND 6 EC: 3.1.3.48 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606 KEYWDS PHOSPHATASE PTP, INHIBITOR, PTPN11, ALLOSTERIC, SHP2, HYDROLASE, KEYWDS 2 HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.FODOR,T.STAMS REVDAT 3 18-OCT-23 7JVN 1 REMARK REVDAT 2 09-DEC-20 7JVN 1 JRNL REVDAT 1 23-SEP-20 7JVN 0 JRNL AUTH M.J.LAMARCHE,M.ACKER,A.ARGINTARU,D.BAUER,J.BOISCLAIR,H.CHAN, JRNL AUTH 2 C.H.CHEN,Y.N.CHEN,Z.CHEN,Z.DENG,M.DORE,D.DUNSTAN,J.FAN, JRNL AUTH 3 P.FEKKES,B.FIRESTONE,M.FODOR,J.GARCIA-FORTANET,P.D.FORTIN, JRNL AUTH 4 C.FRIDRICH,J.GIRALDES,M.GLICK,D.GRUNENFELDER,H.X.HAO, JRNL AUTH 5 M.HENTEMANN,S.HO,A.JOUK,Z.B.KANG,R.KARKI,M.KATO,N.KEEN, JRNL AUTH 6 R.KOENIG,L.R.LABONTE,J.LARROW,G.LIU,S.LIU,D.MAJUMDAR, JRNL AUTH 7 S.MATHIEU,M.J.MEYER,M.MOHSENI,R.NTAGANDA,M.PALERMO,L.PEREZ, JRNL AUTH 8 M.PU,T.RAMSEY,J.REILLY,P.SARVER,W.R.SELLERS,M.SENDZIK, JRNL AUTH 9 M.D.SHULTZ,J.SLISZ,K.SLOCUM,T.SMITH,S.SPENCE,T.STAMS, JRNL AUTH10 C.STRAUB,V.TAMEZ JR.,B.B.TOURE,C.TOWLER,P.WANG,H.WANG, JRNL AUTH11 S.L.WILLIAMS,F.YANG,B.YU,J.H.ZHANG,S.ZHU JRNL TITL IDENTIFICATION OF TNO155, AN ALLOSTERIC SHP2 INHIBITOR FOR JRNL TITL 2 THE TREATMENT OF CANCER. JRNL REF J.MED.CHEM. V. 63 13578 2020 JRNL REFN ISSN 0022-2623 JRNL PMID 32910655 JRNL DOI 10.1021/ACS.JMEDCHEM.0C01170 REMARK 2 REMARK 2 RESOLUTION. 1.92 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 (19-MAR-2020) REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.92 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 107.37 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 81963 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.183 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.214 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010 REMARK 3 FREE R VALUE TEST SET COUNT : 4106 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 51 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.92 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.93 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.82 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1640 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2084 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1556 REMARK 3 BIN R VALUE (WORKING SET) : 0.2069 REMARK 3 BIN FREE R VALUE : 0.2374 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.12 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 84 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7673 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 83 REMARK 3 SOLVENT ATOMS : 738 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 27.46 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.49 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.19740 REMARK 3 B22 (A**2) : 3.01370 REMARK 3 B33 (A**2) : 3.18360 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.02350 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.230 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.150 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.133 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.146 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.132 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.941 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 7946 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 10728 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 2849 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 1346 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 7946 ; 10.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 994 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 7147 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.93 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.40 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.78 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7JVN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-AUG-20. REMARK 100 THE DEPOSITION ID IS D_1000251449. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-AUG-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.16 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 82027 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.917 REMARK 200 RESOLUTION RANGE LOW (A) : 214.736 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07600 REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.92 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.50 REMARK 200 R MERGE FOR SHELL (I) : 0.47500 REMARK 200 R SYM FOR SHELL (I) : 0.47500 REMARK 200 FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: BUSTER REMARK 200 STARTING MODEL: 2SHP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17% PEG 3350 AND 200 MM AMMONIUM REMARK 280 PHOSPHATE, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 107.36800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 SER A 3 REMARK 465 LYS A 35 REMARK 465 SER A 36 REMARK 465 HIS A 85 REMARK 465 GLU A 90 REMARK 465 LYS A 91 REMARK 465 ASN A 92 REMARK 465 GLY A 93 REMARK 465 ASP A 94 REMARK 465 VAL A 95 REMARK 465 SER A 140 REMARK 465 GLN A 141 REMARK 465 SER A 142 REMARK 465 HIS A 143 REMARK 465 ASP A 156 REMARK 465 LYS A 157 REMARK 465 GLY A 158 REMARK 465 GLU A 159 REMARK 465 SER A 160 REMARK 465 ASN A 161 REMARK 465 ASP A 162 REMARK 465 GLY A 163 REMARK 465 LYS A 164 REMARK 465 ALA A 237 REMARK 465 GLU A 238 REMARK 465 THR A 239 REMARK 465 THR A 240 REMARK 465 ASP A 241 REMARK 465 LYS A 242 REMARK 465 VAL A 243 REMARK 465 LYS A 244 REMARK 465 ASN A 298 REMARK 465 GLU A 299 REMARK 465 PRO A 300 REMARK 465 VAL A 301 REMARK 465 GLU A 313 REMARK 465 PHE A 314 REMARK 465 GLU A 315 REMARK 465 THR A 316 REMARK 465 LYS A 317 REMARK 465 CYS A 318 REMARK 465 ASN A 319 REMARK 465 ASN A 320 REMARK 465 SER A 321 REMARK 465 LYS A 322 REMARK 465 PRO A 323 REMARK 465 LYS A 324 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 SER B 3 REMARK 465 HIS B 84 REMARK 465 HIS B 85 REMARK 465 GLY B 86 REMARK 465 GLU B 90 REMARK 465 LYS B 91 REMARK 465 ASN B 92 REMARK 465 GLY B 93 REMARK 465 ASP B 94 REMARK 465 VAL B 95 REMARK 465 SER B 140 REMARK 465 GLN B 141 REMARK 465 SER B 142 REMARK 465 HIS B 143 REMARK 465 GLY B 154 REMARK 465 ASP B 155 REMARK 465 ASP B 156 REMARK 465 LYS B 157 REMARK 465 GLY B 158 REMARK 465 GLU B 159 REMARK 465 SER B 160 REMARK 465 ASN B 161 REMARK 465 ASP B 162 REMARK 465 GLY B 163 REMARK 465 LYS B 164 REMARK 465 LEU B 236 REMARK 465 ALA B 237 REMARK 465 GLU B 238 REMARK 465 THR B 239 REMARK 465 THR B 240 REMARK 465 ASP B 241 REMARK 465 LYS B 242 REMARK 465 VAL B 243 REMARK 465 LYS B 244 REMARK 465 ASP B 294 REMARK 465 GLY B 295 REMARK 465 ASP B 296 REMARK 465 PRO B 297 REMARK 465 ASN B 298 REMARK 465 GLU B 299 REMARK 465 PRO B 300 REMARK 465 GLU B 313 REMARK 465 PHE B 314 REMARK 465 GLU B 315 REMARK 465 THR B 316 REMARK 465 LYS B 317 REMARK 465 CYS B 318 REMARK 465 ASN B 319 REMARK 465 ASN B 320 REMARK 465 SER B 321 REMARK 465 LYS B 322 REMARK 465 PRO B 323 REMARK 465 LYS B 324 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 62 164.40 179.08 REMARK 500 LEU A 177 -4.95 79.58 REMARK 500 TYR A 375 -5.82 78.18 REMARK 500 CYS A 459 -122.86 -128.70 REMARK 500 SER A 460 -73.70 -96.10 REMARK 500 ILE A 463 -36.04 -132.55 REMARK 500 VAL A 505 104.30 78.95 REMARK 500 VAL B 181 36.27 -99.18 REMARK 500 TYR B 375 -9.43 76.49 REMARK 500 LYS B 389 142.86 -171.00 REMARK 500 CYS B 459 -124.40 -134.10 REMARK 500 SER B 460 -73.00 -96.50 REMARK 500 ILE B 463 -36.98 -131.64 REMARK 500 ASP B 485 56.21 -91.82 REMARK 500 VAL B 505 101.90 81.70 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B1065 DISTANCE = 6.86 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VKP A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 A 605 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue VKP B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 B 602 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 B 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue PO4 B 604 DBREF 7JVN A 1 525 UNP Q06124 PTN11_HUMAN 1 525 DBREF 7JVN B 1 525 UNP Q06124 PTN11_HUMAN 1 525 SEQRES 1 A 525 MET THR SER ARG ARG TRP PHE HIS PRO ASN ILE THR GLY SEQRES 2 A 525 VAL GLU ALA GLU ASN LEU LEU LEU THR ARG GLY VAL ASP SEQRES 3 A 525 GLY SER PHE LEU ALA ARG PRO SER LYS SER ASN PRO GLY SEQRES 4 A 525 ASP PHE THR LEU SER VAL ARG ARG ASN GLY ALA VAL THR SEQRES 5 A 525 HIS ILE LYS ILE GLN ASN THR GLY ASP TYR TYR ASP LEU SEQRES 6 A 525 TYR GLY GLY GLU LYS PHE ALA THR LEU ALA GLU LEU VAL SEQRES 7 A 525 GLN TYR TYR MET GLU HIS HIS GLY GLN LEU LYS GLU LYS SEQRES 8 A 525 ASN GLY ASP VAL ILE GLU LEU LYS TYR PRO LEU ASN CYS SEQRES 9 A 525 ALA ASP PRO THR SER GLU ARG TRP PHE HIS GLY HIS LEU SEQRES 10 A 525 SER GLY LYS GLU ALA GLU LYS LEU LEU THR GLU LYS GLY SEQRES 11 A 525 LYS HIS GLY SER PHE LEU VAL ARG GLU SER GLN SER HIS SEQRES 12 A 525 PRO GLY ASP PHE VAL LEU SER VAL ARG THR GLY ASP ASP SEQRES 13 A 525 LYS GLY GLU SER ASN ASP GLY LYS SER LYS VAL THR HIS SEQRES 14 A 525 VAL MET ILE ARG CYS GLN GLU LEU LYS TYR ASP VAL GLY SEQRES 15 A 525 GLY GLY GLU ARG PHE ASP SER LEU THR ASP LEU VAL GLU SEQRES 16 A 525 HIS TYR LYS LYS ASN PRO MET VAL GLU THR LEU GLY THR SEQRES 17 A 525 VAL LEU GLN LEU LYS GLN PRO LEU ASN THR THR ARG ILE SEQRES 18 A 525 ASN ALA ALA GLU ILE GLU SER ARG VAL ARG GLU LEU SER SEQRES 19 A 525 LYS LEU ALA GLU THR THR ASP LYS VAL LYS GLN GLY PHE SEQRES 20 A 525 TRP GLU GLU PHE GLU THR LEU GLN GLN GLN GLU CYS LYS SEQRES 21 A 525 LEU LEU TYR SER ARG LYS GLU GLY GLN ARG GLN GLU ASN SEQRES 22 A 525 LYS ASN LYS ASN ARG TYR LYS ASN ILE LEU PRO PHE ASP SEQRES 23 A 525 HIS THR ARG VAL VAL LEU HIS ASP GLY ASP PRO ASN GLU SEQRES 24 A 525 PRO VAL SER ASP TYR ILE ASN ALA ASN ILE ILE MET PRO SEQRES 25 A 525 GLU PHE GLU THR LYS CYS ASN ASN SER LYS PRO LYS LYS SEQRES 26 A 525 SER TYR ILE ALA THR GLN GLY CYS LEU GLN ASN THR VAL SEQRES 27 A 525 ASN ASP PHE TRP ARG MET VAL PHE GLN GLU ASN SER ARG SEQRES 28 A 525 VAL ILE VAL MET THR THR LYS GLU VAL GLU ARG GLY LYS SEQRES 29 A 525 SER LYS CYS VAL LYS TYR TRP PRO ASP GLU TYR ALA LEU SEQRES 30 A 525 LYS GLU TYR GLY VAL MET ARG VAL ARG ASN VAL LYS GLU SEQRES 31 A 525 SER ALA ALA HIS ASP TYR THR LEU ARG GLU LEU LYS LEU SEQRES 32 A 525 SER LYS VAL GLY GLN GLY ASN THR GLU ARG THR VAL TRP SEQRES 33 A 525 GLN TYR HIS PHE ARG THR TRP PRO ASP HIS GLY VAL PRO SEQRES 34 A 525 SER ASP PRO GLY GLY VAL LEU ASP PHE LEU GLU GLU VAL SEQRES 35 A 525 HIS HIS LYS GLN GLU SER ILE MET ASP ALA GLY PRO VAL SEQRES 36 A 525 VAL VAL HIS CYS SER ALA GLY ILE GLY ARG THR GLY THR SEQRES 37 A 525 PHE ILE VAL ILE ASP ILE LEU ILE ASP ILE ILE ARG GLU SEQRES 38 A 525 LYS GLY VAL ASP CYS ASP ILE ASP VAL PRO LYS THR ILE SEQRES 39 A 525 GLN MET VAL ARG SER GLN ARG SER GLY MET VAL GLN THR SEQRES 40 A 525 GLU ALA GLN TYR ARG PHE ILE TYR MET ALA VAL GLN HIS SEQRES 41 A 525 TYR ILE GLU THR LEU SEQRES 1 B 525 MET THR SER ARG ARG TRP PHE HIS PRO ASN ILE THR GLY SEQRES 2 B 525 VAL GLU ALA GLU ASN LEU LEU LEU THR ARG GLY VAL ASP SEQRES 3 B 525 GLY SER PHE LEU ALA ARG PRO SER LYS SER ASN PRO GLY SEQRES 4 B 525 ASP PHE THR LEU SER VAL ARG ARG ASN GLY ALA VAL THR SEQRES 5 B 525 HIS ILE LYS ILE GLN ASN THR GLY ASP TYR TYR ASP LEU SEQRES 6 B 525 TYR GLY GLY GLU LYS PHE ALA THR LEU ALA GLU LEU VAL SEQRES 7 B 525 GLN TYR TYR MET GLU HIS HIS GLY GLN LEU LYS GLU LYS SEQRES 8 B 525 ASN GLY ASP VAL ILE GLU LEU LYS TYR PRO LEU ASN CYS SEQRES 9 B 525 ALA ASP PRO THR SER GLU ARG TRP PHE HIS GLY HIS LEU SEQRES 10 B 525 SER GLY LYS GLU ALA GLU LYS LEU LEU THR GLU LYS GLY SEQRES 11 B 525 LYS HIS GLY SER PHE LEU VAL ARG GLU SER GLN SER HIS SEQRES 12 B 525 PRO GLY ASP PHE VAL LEU SER VAL ARG THR GLY ASP ASP SEQRES 13 B 525 LYS GLY GLU SER ASN ASP GLY LYS SER LYS VAL THR HIS SEQRES 14 B 525 VAL MET ILE ARG CYS GLN GLU LEU LYS TYR ASP VAL GLY SEQRES 15 B 525 GLY GLY GLU ARG PHE ASP SER LEU THR ASP LEU VAL GLU SEQRES 16 B 525 HIS TYR LYS LYS ASN PRO MET VAL GLU THR LEU GLY THR SEQRES 17 B 525 VAL LEU GLN LEU LYS GLN PRO LEU ASN THR THR ARG ILE SEQRES 18 B 525 ASN ALA ALA GLU ILE GLU SER ARG VAL ARG GLU LEU SER SEQRES 19 B 525 LYS LEU ALA GLU THR THR ASP LYS VAL LYS GLN GLY PHE SEQRES 20 B 525 TRP GLU GLU PHE GLU THR LEU GLN GLN GLN GLU CYS LYS SEQRES 21 B 525 LEU LEU TYR SER ARG LYS GLU GLY GLN ARG GLN GLU ASN SEQRES 22 B 525 LYS ASN LYS ASN ARG TYR LYS ASN ILE LEU PRO PHE ASP SEQRES 23 B 525 HIS THR ARG VAL VAL LEU HIS ASP GLY ASP PRO ASN GLU SEQRES 24 B 525 PRO VAL SER ASP TYR ILE ASN ALA ASN ILE ILE MET PRO SEQRES 25 B 525 GLU PHE GLU THR LYS CYS ASN ASN SER LYS PRO LYS LYS SEQRES 26 B 525 SER TYR ILE ALA THR GLN GLY CYS LEU GLN ASN THR VAL SEQRES 27 B 525 ASN ASP PHE TRP ARG MET VAL PHE GLN GLU ASN SER ARG SEQRES 28 B 525 VAL ILE VAL MET THR THR LYS GLU VAL GLU ARG GLY LYS SEQRES 29 B 525 SER LYS CYS VAL LYS TYR TRP PRO ASP GLU TYR ALA LEU SEQRES 30 B 525 LYS GLU TYR GLY VAL MET ARG VAL ARG ASN VAL LYS GLU SEQRES 31 B 525 SER ALA ALA HIS ASP TYR THR LEU ARG GLU LEU LYS LEU SEQRES 32 B 525 SER LYS VAL GLY GLN GLY ASN THR GLU ARG THR VAL TRP SEQRES 33 B 525 GLN TYR HIS PHE ARG THR TRP PRO ASP HIS GLY VAL PRO SEQRES 34 B 525 SER ASP PRO GLY GLY VAL LEU ASP PHE LEU GLU GLU VAL SEQRES 35 B 525 HIS HIS LYS GLN GLU SER ILE MET ASP ALA GLY PRO VAL SEQRES 36 B 525 VAL VAL HIS CYS SER ALA GLY ILE GLY ARG THR GLY THR SEQRES 37 B 525 PHE ILE VAL ILE ASP ILE LEU ILE ASP ILE ILE ARG GLU SEQRES 38 B 525 LYS GLY VAL ASP CYS ASP ILE ASP VAL PRO LYS THR ILE SEQRES 39 B 525 GLN MET VAL ARG SER GLN ARG SER GLY MET VAL GLN THR SEQRES 40 B 525 GLU ALA GLN TYR ARG PHE ILE TYR MET ALA VAL GLN HIS SEQRES 41 B 525 TYR ILE GLU THR LEU HET VKP A 601 24 HET PO4 A 602 5 HET PO4 A 603 5 HET PO4 A 604 5 HET PO4 A 605 5 HET VKP B 601 24 HET PO4 B 602 5 HET PO4 B 603 5 HET PO4 B 604 5 HETNAM VKP 6-(4-AMINO-4-METHYLPIPERIDIN-1-YL)-3-[(2,3- HETNAM 2 VKP DICHLOROPHENYL)SULFANYL]PYRAZIN-2-AMINE HETNAM PO4 PHOSPHATE ION FORMUL 3 VKP 2(C16 H19 CL2 N5 S) FORMUL 4 PO4 7(O4 P 3-) FORMUL 12 HOH *738(H2 O) HELIX 1 AA1 THR A 12 ARG A 23 1 12 HELIX 2 AA2 THR A 73 HIS A 84 1 12 HELIX 3 AA3 SER A 118 GLY A 130 1 13 HELIX 4 AA4 SER A 189 ASN A 200 1 12 HELIX 5 AA5 GLU A 225 LYS A 235 1 11 HELIX 6 AA6 GLY A 246 GLN A 257 1 12 HELIX 7 AA7 GLU A 258 LEU A 262 5 5 HELIX 8 AA8 ARG A 265 ARG A 270 1 6 HELIX 9 AA9 GLN A 271 ASN A 277 5 7 HELIX 10 AB1 LEU A 334 ASN A 336 5 3 HELIX 11 AB2 THR A 337 ASN A 349 1 13 HELIX 12 AB3 PRO A 432 SER A 448 1 17 HELIX 13 AB4 ILE A 463 GLY A 483 1 21 HELIX 14 AB5 ASP A 489 SER A 499 1 11 HELIX 15 AB6 THR A 507 THR A 524 1 18 HELIX 16 AB7 THR B 12 GLY B 24 1 13 HELIX 17 AB8 THR B 73 GLU B 83 1 11 HELIX 18 AB9 SER B 118 GLY B 130 1 13 HELIX 19 AC1 SER B 189 ASN B 200 1 12 HELIX 20 AC2 GLU B 225 LYS B 235 1 11 HELIX 21 AC3 GLY B 246 GLN B 257 1 12 HELIX 22 AC4 GLU B 258 LEU B 262 5 5 HELIX 23 AC5 ARG B 265 ARG B 270 1 6 HELIX 24 AC6 GLN B 271 ASN B 277 5 7 HELIX 25 AC7 LEU B 334 ASN B 336 5 3 HELIX 26 AC8 THR B 337 ASN B 349 1 13 HELIX 27 AC9 PRO B 432 SER B 448 1 17 HELIX 28 AD1 GLY B 464 GLY B 483 1 20 HELIX 29 AD2 ASP B 489 SER B 499 1 11 HELIX 30 AD3 THR B 507 THR B 524 1 18 SHEET 1 AA1 6 LYS A 70 PHE A 71 0 SHEET 2 AA1 6 TYR A 63 LEU A 65 -1 N TYR A 63 O PHE A 71 SHEET 3 AA1 6 ALA A 50 GLN A 57 -1 N GLN A 57 O ASP A 64 SHEET 4 AA1 6 PHE A 41 ARG A 47 -1 N LEU A 43 O ILE A 54 SHEET 5 AA1 6 SER A 28 PRO A 33 -1 N SER A 28 O ARG A 46 SHEET 6 AA1 6 TYR A 100 PRO A 101 1 O TYR A 100 N PHE A 29 SHEET 1 AA2 5 LYS A 178 ASP A 180 0 SHEET 2 AA2 5 LYS A 166 GLN A 175 -1 N ARG A 173 O ASP A 180 SHEET 3 AA2 5 PHE A 147 THR A 153 -1 N LEU A 149 O VAL A 170 SHEET 4 AA2 5 SER A 134 ARG A 138 -1 N SER A 134 O ARG A 152 SHEET 5 AA2 5 GLN A 214 PRO A 215 1 O GLN A 214 N PHE A 135 SHEET 1 AA3 2 MET A 202 VAL A 203 0 SHEET 2 AA3 2 VAL A 209 LEU A 210 -1 O LEU A 210 N MET A 202 SHEET 1 AA4 2 ILE A 221 ASN A 222 0 SHEET 2 AA4 2 ASP A 487 ILE A 488 -1 O ILE A 488 N ILE A 221 SHEET 1 AA5 8 ALA A 307 ILE A 310 0 SHEET 2 AA5 8 TYR A 327 THR A 330 -1 O TYR A 327 N ILE A 310 SHEET 3 AA5 8 VAL A 455 HIS A 458 1 O VAL A 457 N ILE A 328 SHEET 4 AA5 8 VAL A 352 MET A 355 1 N VAL A 354 O VAL A 456 SHEET 5 AA5 8 GLN A 408 PHE A 420 1 O TYR A 418 N ILE A 353 SHEET 6 AA5 8 TYR A 396 LYS A 405 -1 N LEU A 403 O ARG A 413 SHEET 7 AA5 8 MET A 383 ALA A 392 -1 N ARG A 384 O SER A 404 SHEET 8 AA5 8 LEU A 377 TYR A 380 -1 N TYR A 380 O MET A 383 SHEET 1 AA6 2 VAL A 360 GLU A 361 0 SHEET 2 AA6 2 LYS A 364 SER A 365 -1 O LYS A 364 N GLU A 361 SHEET 1 AA7 6 LYS B 70 PHE B 71 0 SHEET 2 AA7 6 TYR B 63 LEU B 65 -1 N TYR B 63 O PHE B 71 SHEET 3 AA7 6 ALA B 50 GLN B 57 -1 N GLN B 57 O ASP B 64 SHEET 4 AA7 6 PHE B 41 ARG B 47 -1 N LEU B 43 O ILE B 54 SHEET 5 AA7 6 SER B 28 PRO B 33 -1 N SER B 28 O ARG B 46 SHEET 6 AA7 6 TYR B 100 PRO B 101 1 O TYR B 100 N PHE B 29 SHEET 1 AA8 5 LYS B 178 ASP B 180 0 SHEET 2 AA8 5 VAL B 167 GLN B 175 -1 N GLN B 175 O LYS B 178 SHEET 3 AA8 5 PHE B 147 ARG B 152 -1 N PHE B 147 O ILE B 172 SHEET 4 AA8 5 SER B 134 ARG B 138 -1 N SER B 134 O ARG B 152 SHEET 5 AA8 5 GLN B 214 PRO B 215 1 O GLN B 214 N PHE B 135 SHEET 1 AA9 2 MET B 202 VAL B 203 0 SHEET 2 AA9 2 VAL B 209 LEU B 210 -1 O LEU B 210 N MET B 202 SHEET 1 AB1 2 ILE B 221 ASN B 222 0 SHEET 2 AB1 2 ASP B 487 ILE B 488 -1 O ILE B 488 N ILE B 221 SHEET 1 AB2 9 ARG B 289 VAL B 291 0 SHEET 2 AB2 9 TYR B 304 ILE B 310 -1 O ALA B 307 N VAL B 290 SHEET 3 AB2 9 TYR B 327 THR B 330 -1 O TYR B 327 N ILE B 310 SHEET 4 AB2 9 VAL B 455 HIS B 458 1 O VAL B 457 N ILE B 328 SHEET 5 AB2 9 VAL B 352 MET B 355 1 N VAL B 354 O VAL B 456 SHEET 6 AB2 9 GLN B 408 PHE B 420 1 O TYR B 418 N ILE B 353 SHEET 7 AB2 9 TYR B 396 LYS B 405 -1 N THR B 397 O HIS B 419 SHEET 8 AB2 9 MET B 383 ALA B 392 -1 N ARG B 384 O SER B 404 SHEET 9 AB2 9 LEU B 377 TYR B 380 -1 N TYR B 380 O MET B 383 SHEET 1 AB3 2 VAL B 360 GLU B 361 0 SHEET 2 AB3 2 LYS B 364 SER B 365 -1 O LYS B 364 N GLU B 361 SITE 1 AC1 11 ARG A 111 PHE A 113 THR A 218 THR A 219 SITE 2 AC1 11 GLU A 249 GLU A 250 THR A 253 LEU A 254 SITE 3 AC1 11 PRO A 491 LYS A 492 HOH A 712 SITE 1 AC2 4 ARG A 32 SER A 34 THR A 42 HOH A 784 SITE 1 AC3 4 PHE A 346 ASN A 349 ARG A 413 HOH A 724 SITE 1 AC4 5 LYS A 131 ASN A 217 ARG A 220 HOH A 702 SITE 2 AC4 5 HOH A 704 SITE 1 AC5 1 ARG A 138 SITE 1 AC6 13 ARG B 111 PHE B 113 HIS B 114 THR B 218 SITE 2 AC6 13 THR B 219 GLU B 249 GLU B 250 THR B 253 SITE 3 AC6 13 LEU B 254 GLN B 257 PRO B 491 LYS B 492 SITE 4 AC6 13 HOH B 720 SITE 1 AC7 7 ARG B 32 SER B 34 LYS B 35 SER B 36 SITE 2 AC7 7 THR B 42 HOH B 709 HOH B 808 SITE 1 AC8 5 PHE B 346 GLN B 347 ASN B 349 ARG B 413 SITE 2 AC8 5 HOH B 726 SITE 1 AC9 2 ARG B 138 MET B 171 CRYST1 46.090 214.736 55.840 90.00 97.09 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021697 0.000000 0.002699 0.00000 SCALE2 0.000000 0.004657 0.000000 0.00000 SCALE3 0.000000 0.000000 0.018046 0.00000